Treatment Past Webinars
Latest Developments into Ovarian Cancer
In this webinar, Dr Yoland Antill, a medical oncologist talks about some of the current research in ovarian cancer including the SOLO2 trial looking at the use of Olaparib in early ovarian cancer.
Another medical oncologist, Dr Tarek Meniawy, talks about clinical trials and new therapies in ovarian cancer including PARP inhibitors, immunotherapy and the timing of different treatments.
Ms Vicki Sidoti, who was diagnosed with stage 4 ovarian cancer five years ago shares her experience of being on a clinical trial and why the trial has been so important to her.
PARP Inhibitors And Ovarian Cancer
In this webinar Professor Jonathan Ledermann shares his extensive expertise in the area of PARP inhibitors and ovarian cancer. Professor Ledermann discusses why progress in treatment of advanced ovarian cancer has been poor, looks at the history and landscape of PARP inhibitors, and reviews the early results that led to the pivotal trial that resulted in the licensing of Olaparib including updated survival data
This webinar also features Kristin Young, who shares her experience of living with ovarian cancer and participating in the clinical trials for Olaparib.
Clinical Trials & Research
In this webinar we share information about ovarian cancer clinical trials: what they are, how they work and where women living with ovarian cancer can find out more.
The webinar outlines drug approval – what it is, who it will be listed for and who pays – where trials are heading and progress made in the area of ovarian cancer prevention.